Early Evaluation of IMAGINATOR 2.0 Intervention Targeting Self-Harm in Young People: Single-Arm Feasibility Trial
JMIR Formative Research · 2026-01-26 · 10 · e79496
DOI: 10.2196/79496 ↗At a glance
Klinische Studie in JMIR Formative Research, published online on 2026-01-26. Written by Athina Servi and 9 co-authors. Institution: Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom. Major MEDLINE topics: Imagery, Psychotherapy, Mobile Applications, Self-Injurious Behavior. Cited 6 times so far (Crossref); 85 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Self-harm (SH) affects around 20% of all young people in the United Kingdom. Treatment options for SH remain limited and those available are long and costly and may not suit all young people. There is an urgent need to develop new scalable interventions to address this gap. IMAGINATOR is a novel imagery-based intervention targeting SH initially developed for individuals aged 16 to 25 years. It is a blended digital intervention delivering functional imagery training via therapy sessions and a smartphone app.
Objective
This study aimed to pilot a new version of the app, IMAGINATOR 2.0, extended to adolescents from the age of 12 years and coproduced with a diverse group of young people with lived experience. Our aim was also to test the feasibility and acceptability of delivering IMAGINATOR 2.0 in secondary mental health services.
Methods
A total of 4 co-design workshops were conducted online with UK-based lived-experience co-designers aged 14-25 years to develop the IMAGINATOR 2.0 app. The intervention was then piloted with participants recruited from West London NHS Trust Tier 2 Child and Adolescent Mental Health Services and adult Mental Health Integrated Network Teams. Participants received 3 face-to-face functional imagery training sessions in which the app was introduced and 5 brief phone support sessions. Outcome assessments were conducted after completing therapy, approximately 3 months post baseline. Two focus groups gathered the therapists’ perspectives on IMAGINATOR 2.0’s acceptability and means of improvement. For quantitative data, descriptives are reported. Qualitative data were analyzed using a coproduced thematic analysis method with young people with lived experiences.
Results
Overall, 83 participants were referred, and 29 (gender: n=28 women, n=1 transgender; mean age 18.9, SD 3.74 years) were eligible and completed screening. Of the 27 participants who started, 59% (n=16) completed therapy per protocol, while only 15 (55.6%) completed the quantitative outcome assessment. There was an overall reduction in the number of SH episodes over 3 months from pre- to postintervention (baseline: median 7, IQR 3.5-21.5 months; postintervention: median 0, IQR 0-7 months; median difference=–6.5; r=0.69). Six themes were identified through thematic analysis of therapists’ feedback, including mental imagery’s potential and boundaries, therapy expectations, experience and effectiveness, accessibility of digital support, and adaptation of the IMAGINATOR 2.0 app to complement care pathways. The app was valued by therapists who highlighted the need for an intervention like IMAGINATOR 2.0 in their services.
Conclusions
IMAGINATOR 2.0 shows initial promise as an acceptable brief intervention targeting SH in young people under adolescent and adult mental health services. Challenges with attrition need to be addressed for a definitive randomized controlled trial to test the intervention efficacy. Trial Registration ClinicalTrials.gov NCT06311084; https://clinicaltrials.gov/study/NCT06311084
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
- West London NHS Trust, London, United Kingdom.
- Dyson School of Design Engineering, Imperial College London, London, United Kingdom.
- Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
- School of Public Health, Imperial College London, London, United Kingdom.
- NIHR Imperial Biomedical Research Centre, London, England, United Kingdom.
ORCID profiles: Athina Servi, Emily Gardner-Bougaard, Saida Mohamed, Aaron McDermott, Rachel Rodrigues, Ben Aveyard, Nejra Van Zalk, Adam Hampshire, Lindsay Dewa, Martina Di Simplicio
Cite
APA
Servi, A., Gardner-Bougaard, E., Mohamed, S., McDermott, A., Rodrigues, R., Aveyard, B., Van Zalk, N., Hampshire, A., Dewa, L., & Di Simplicio, M. (2026). Early Evaluation of IMAGINATOR 2.0 Intervention Targeting Self-Harm in Young People: Single-Arm Feasibility Trial. JMIR Formative Research, 10, e79496. https://doi.org/10.2196/79496
Vancouver
Servi A, Gardner-Bougaard E, Mohamed S, McDermott A, Rodrigues R, Aveyard B, et al. Early Evaluation of IMAGINATOR 2.0 Intervention Targeting Self-Harm in Young People: Single-Arm Feasibility Trial. JMIR Formative Research. 2026;10:e79496. doi:10.2196/79496
BibTeX
@article{Servi2026,
author = {Servi, Athina and Gardner-Bougaard, Emily and Mohamed, Saida and McDermott, Aaron and Rodrigues, Rachel and Aveyard, Ben and Van Zalk, Nejra and Hampshire, Adam and Dewa, Lindsay and Di Simplicio, Martina},
title = {Early Evaluation of IMAGINATOR 2.0 Intervention Targeting Self-Harm in Young People: Single-Arm Feasibility Trial},
journal = {JMIR Formative Research},
year = {2026},
volume = {10},
pages = {e79496},
doi = {10.2196/79496}
}
EUVIMED